Andreas Linkermann

Andreas Linkermann, M.D., is a Visiting Professor in the Department of Medicine (Nephrology) at Heidelberg University's Mannheim Medical Faculty. His research focuses on kidney transplantation, acute kidney injury, and cell death mechanisms including necroptosis, pyroptosis, and ferroptosis. He leads an interdisciplinary team of clinicians and scientists investigating how to inhibit clinically relevant necrotic cell death pathways and their associated inflammatory responses (necroinflammation).

His work spans molecular mechanisms of regulated necrosis, drug-induced kidney injury, and novel therapeutic targets for diseases like adrenocortical carcinoma and cardiomyopathy. Notable contributions include elucidating ferroptosis's role in kidney tubular injury and identifying vitamin K's non-canonical cycle as a ferroptosis suppressor. Linkermann's team employs advanced mouse models and pharmacological tools to study these pathways, with implications for organ transplantation and acute injury management.

Key publications include studies on ferroptosis regulation via glucocorticoids (Science Advances 2022), vitamin K's anti-ferroptotic effects (Nature 2022), and necroptosis's dual role in ischemia-reperfusion injury (PNAS 2013). His research bridges clinical nephrology with molecular biology, emphasizing translational applications for kidney and cardiovascular diseases.

No specific awards or grants are listed in the provided text. His lab collaborates with biotechnologists, biochemists, and molecular biologists to advance understanding of necroinflammation and its therapeutic modulation.